Genomics

Skin Genomics Platform DermTech Announces New Appointment

DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today the appointment of Monica Tellado, Senior Vice President, Finance at Gilead Sciences to its Board of Directors.

“We are so fortunate to welcome Monica to our Board of Directors,” said Matt Posard, DermTech’s Chairman of the Board. “As the company continues to scale for growth and expansion, Monica brings critical perspectives on commercializing new products and driving operational excellence to support business growth and efficiencies.”

Monica’s experience includes 18 years at Gilead Sciences, in roles of progressive leadership responsibility up to and including her current role as Senior Vice President Finance. She’s been responsible for the U.S. and Latin American commercial markets, led preparations to enter new markets and launch new products within Gilead’s HIV, Liver, Cardiopulmonary, and Oncology business units and was responsible for the U.S. Liver Disease business unit including a P&L of nearly $2 billion. In her current role as Senior Vice President, Finance, Monica oversees global financial planning and analysis as well as investor relations.

Monica received a Master of Business Administration from Carnegie Mellon University.

“It is a great pleasure to join the DermTech Board of Directors at such an exciting and important point in the Company’s history,” said Ms. Tellado. “I look forward to contributing to DermTech’s vision to lead the genomics revolution in skin health, particularly as we step into this crucial next phase of growth.”

For more such updates and perspectives around Digital Innovation, IoT, Data Infrastructure, AI & Cybsercurity, go to AI-Techpark.com.

Related posts

Illumina Genomics Forum to Feature Anne Wojcicki

PR Newswire

Fabric Genomics Expands Leadership Team in Precision Medicine

Business Wire

Delfi Researchers and Founders to Present at American Association

PR Newswire